Systematic Review

Published on 24 Oct 2023

Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis

in Pharmacoepidemiology

Erye Zhou
Jian Wu
Keqin Zeng
Mingjun Wang
Yufeng Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226528

2,840 views
2 citations

Original Research

Published on 20 Oct 2023

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database

in Pharmacoepidemiology

Rachel Prevost
Basile Chretien
Elise-Marie Minoc
Charles Dolladille
Angélique Da-Silva
Ahmad Nehme
Florence Joly
Véronique Lelong-Boulouard
Etienne Bastien

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1278682

2,804 views
2 citations

Opinion

Published on 11 Oct 2023

Nutrivigilance: the road less traveled

in Pharmacoepidemiology

Vijay Ronit Luthra
Hale Z. Toklu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274810

3,080 views
2 citations

Policy and Practice Reviews

Published on 11 Oct 2023

A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence

in Pharmacoepidemiology

Kristoffer Larsen
Ryan N. Walton
Mohamed Elsayed
Andrey Ipatov
Faye Townsend-Holyoake
Sebastian F. A. Axelsson
Nacho Quinones
Rudiger Papsch
Jennifer Givens
Alexander Bedenkov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233617

6,594 views

Brief Research Report

Published on 10 Oct 2023

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status

in Pharmacoepidemiology

José Manuel Ramos-Rincón
Héctor Pinargote-Celorio
Jara Llenas-García
Oscar Moreno-Pérez
Inmaculada González-Cuello
Pilar Gonzalez-de-la-Aleja
Belén Martínez-López
Sergio Reus
María García-López
Juan Carlos Rodríguez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218650

1,986 views
3 citations

Original Research

Published on 09 Oct 2023

Impact of domiciliary administration of NSAIDs on COVID-19 hospital outcomes: an unCoVer analysis

in Pharmacoepidemiology

Elena Salvador
Cristina Mazzi
Nicoletta De Santis
Giulia Bertoli
Antonija Jonjić
Miran Coklo
Marek Majdan
José L. Peñalvo
Dora Buonfrate

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1252800

1,137 views

Original Research

Published on 02 Oct 2023

Infections associated with clozapine: a pharmacovigilance study using VigiBase®

in Pharmacoepidemiology

Basile Chrétien
Perrine Brazo
Angélique Da Silva
Marion Sassier
Charles Dolladille
Véronique Lelong-Boulouard
Joachim Alexandre
Sophie Fedrizzi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1260915

3,001 views
1 citation

Original Research

Published on 28 Sep 2023

Impact of implementing a vancomycin protocol to reduce kidney toxicity: A comparative study

in Pharmacoepidemiology

Graziella Gasparotto Baiocco
Stephanie Greiner
Mário Borges Rosa
Cecília Dias Flores
Helena M. T. Barros

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154573

2,073 views

Original Research

Published on 25 Sep 2023

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy

in Pharmacoepidemiology

Irma Convertino
Massimiliano Cazzato
Silvia Tillati
Sabrina Giometto
Rosa Gini
Giulia Valdiserra
Emiliano Cappello
Sara Ferraro
Marco Bonaso
Claudia Bartolini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244486

1,658 views

Original Research

Published on 22 Sep 2023

Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study

in Pharmacoepidemiology

Jing Yu
Yan Liu
Ruochen Qu
Ziyang Wang
Yan Zhao
Yuanyuan Zhao
Chunhua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1263618

2,638 views

Original Research

Published on 20 Sep 2023

Translation and validation of the Sindhi version of the general medication adherence scale in patients with chronic diseases

in Pharmacoepidemiology

Md. Ashraful Islam
Wajiha Iffat
Shahlla Imam
Sadia Shakeel
Abdul Rasheed
Atta Abbas Naqvi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1235032

1,664 views

Original Research

Published on 18 Sep 2023

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

in Pharmacoepidemiology

Patricia Marques Soares Valente
Paula Nogueira da Silva
Licínio Esmeraldo da Silva
Wolney de Andrade Martins
Selma Rodrigues de Castilho

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1099545

1,348 views
2 citations

Original Research

Published on 15 Sep 2023

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia

in Pharmacoepidemiology

Maria Giner-Soriano
Dan Ouchi
Roser Vives
Carles Vilaplana-Carnerero
Andrea Molina
Antoni Vallano
Rosa Morros

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237454

1,976 views
2 citations

Original Research

Published on 14 Sep 2023

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

in Pharmacoepidemiology

Wei Wang
Xin Guan
Shuang Wang
Lipeng Shi
Yanfei Zhu
Pengbo Hua
Qiang Guo
Jingqi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249845

2,124 views
2 citations

Original Research

Published on 14 Sep 2023

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Sicen Pan
Hong Zhang
Yongtao Tong
Wei Wu
Yi Huang
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226086

2,250 views
3 citations

Editorial

Published on 12 Sep 2023

Editorial: Women in pharmacoepidemiology: 2021

in Pharmacoepidemiology

Luciane Cruz Lopes
Daniela C. Moga
Tatiane Da Silva Dal Pizzol
Natasa Gisev
Bita Mesgarpour
Anick Bérard

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1278768

1,107 views

Navigation group

Articles

Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database

Nutrivigilance: the road less traveled

A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status

Impact of domiciliary administration of NSAIDs on COVID-19 hospital outcomes: an unCoVer analysis

Infections associated with clozapine: a pharmacovigilance study using VigiBase®

Impact of implementing a vancomycin protocol to reduce kidney toxicity: A comparative study

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy

Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study

Translation and validation of the Sindhi version of the general medication adherence scale in patients with chronic diseases

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

Editorial: Women in pharmacoepidemiology: 2021